Hosted by Dr. Bing Zhang, this Data Science Seminar will explore how cancer proteomics integrates with genomics, epigenomics and transcriptomics to better understand how genetic mutations translate into functional changes in cancer.

Building on large-scale efforts through the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC). Dr. Zhang’s work focuses on using deep learning to analyze post-translational modification patterns and developing computational pipelines to identify tumor-specific antigens for immunotherapy. This approach provides deeper insight into how proteogenomics can illuminate cancer biology and create new opportunities for precision oncology.

About The Speaker

Dr. Bing Zhang is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar, McNair Medical Institute Scholar and professor of molecular and human genetics at Baylor College of Medicine. He directs an internationally recognized research program in cancer protogenomics, integrating genomic and proteomic data to advance understanding of cancer biology and improve diagnosis and treatment. He has published more than 200 peer-reviewed papers, including over two dozen in Nature, Nature Methods, Cell and Cancer Cell. His contributions to computational proteomics were honored with the Gilbert S. Omenn Computational Proteomics Awards in 2023.